Avacta Group (AVCT) Competitors GBX 51 -4.50 (-8.11%) As of 09/29/2025 11:56 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock AVCT vs. ERGO, OXB, SLN, PRTC, HZD, VRP, FARN, ARIX, CIR, and BVXPShould you be buying Avacta Group stock or one of its competitors? The main competitors of Avacta Group include Ergomed (ERGO), Oxford Biomedica (OXB), Silence Therapeutics (SLN), PureTech Health (PRTC), Horizon Discovery Group plc (HZD.L) (HZD), Verona Pharma plc (VRP.L) (VRP), Faron Pharmaceuticals Oy (FARN), Arix Bioscience (ARIX), Circassia Group (CIR), and Bioventix (BVXP). These companies are all part of the "biotechnology" industry. Avacta Group vs. Its Competitors Ergomed Oxford Biomedica Silence Therapeutics PureTech Health Horizon Discovery Group plc (HZD.L) Verona Pharma plc (VRP.L) Faron Pharmaceuticals Oy Arix Bioscience Circassia Group Bioventix Ergomed (LON:ERGO) and Avacta Group (LON:AVCT) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, media sentiment, profitability, analyst recommendations, risk and valuation. Which has more volatility and risk, ERGO or AVCT? Ergomed has a beta of 0.79, indicating that its share price is 21% less volatile than the S&P 500. Comparatively, Avacta Group has a beta of 1.12, indicating that its share price is 12% more volatile than the S&P 500. Does the media prefer ERGO or AVCT? In the previous week, Ergomed's average media sentiment score of 0.00 equaled Avacta Group'saverage media sentiment score. Company Overall Sentiment Ergomed Neutral Avacta Group Neutral Do institutionals & insiders hold more shares of ERGO or AVCT? 71.1% of Ergomed shares are held by institutional investors. Comparatively, 13.5% of Avacta Group shares are held by institutional investors. 18.2% of Ergomed shares are held by company insiders. Comparatively, 54.5% of Avacta Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has better earnings & valuation, ERGO or AVCT? Ergomed has higher revenue and earnings than Avacta Group. Avacta Group is trading at a lower price-to-earnings ratio than Ergomed, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioErgomed£152.09M0.00£15M£0.29N/AAvacta Group£113K1,813.28-£30.08M-£0.15-332.46 Is ERGO or AVCT more profitable? Ergomed has a net margin of 9.87% compared to Avacta Group's net margin of -114.45%. Ergomed's return on equity of 18.08% beat Avacta Group's return on equity.Company Net Margins Return on Equity Return on Assets Ergomed9.87% 18.08% 10.16% Avacta Group -114.45%-74.00%-21.80% SummaryErgomed beats Avacta Group on 8 of the 10 factors compared between the two stocks. Get Avacta Group News Delivered to You Automatically Sign up to receive the latest news and ratings for AVCT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AVCT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AVCT vs. The Competition Export to ExcelMetricAvacta GroupBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£204.90M£226.93M£5.69B£2.59BDividend Yield3.97%3.80%5.78%5.32%P/E Ratio-332.4631.8875.605,406.64Price / Sales1,813.284,565.52520.5198,721.67Price / Cash15.0013.1925.6727.92Price / Book3.46117.0812.828.43Net Income-£30.08M-£90.99M£3.29B£5.89B7 Day Performance-1.92%0.70%1.38%3.63%1 Month Performance-17.07%5.69%4.61%6.09%1 Year Performance-1.92%597.27%66.62%156.75% Avacta Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AVCTAvacta GroupN/AGBX 51-8.1%N/A-1.0%£204.90M£113K-332.46120ERGOErgomedN/AN/AN/AN/A£701.00M£152.09M4,641.386OXBOxford Biomedica1.3139 of 5 starsGBX 578-0.7%GBX 593.67+2.7%+46.3%£694.65M£128.80M-1,384.43891SLNSilence TherapeuticsN/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading VolumePRTCPureTech Health2.5541 of 5 starsGBX 127.80+0.8%GBX 455+256.0%-16.1%£308.87M£6.17M751.76300HZDHorizon Discovery Group plc (HZD.L)N/AN/AN/AN/A£302.98M£54.63M-33.55416VRPVerona Pharma plc (VRP.L)N/AN/AN/AN/A£228MN/A-1.6822Gap UpFARNFaron Pharmaceuticals OyN/AGBX 183-2.4%N/A-20.1%£204.88MN/A-677.7834Gap UpARIXArix BioscienceN/AN/AN/AN/A£183.73M£14.16M1,290.919CIRCircassia GroupN/AN/AN/AN/A£142.66M£27.90M3,400.00111Gap DownBVXPBioventixN/AGBX 2,400-4.0%N/A-35.0%£125.40M£13.66M1,620.3112Positive News Related Companies and Tools Related Companies Ergomed Alternatives Oxford Biomedica Alternatives Silence Therapeutics Alternatives PureTech Health Alternatives Horizon Discovery Group plc (HZD.L) Alternatives Verona Pharma plc (VRP.L) Alternatives Faron Pharmaceuticals Oy Alternatives Arix Bioscience Alternatives Circassia Group Alternatives Bioventix Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:AVCT) was last updated on 9/30/2025 by MarketBeat.com Staff From Our PartnersNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredDefense Billions Flow Into Critical Minerals — Here’s Why Gold’s KeyWhat do missile defense systems and gold miners have in common? More than most investors realize. The Unite...The Tomorrow Investor | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredAn Early Move On The Next Shift In CoinLitecoin is already processing 500,000+ daily transactions, integrated with PayPal and Revolut, and now one fi...Market Tactic | SponsoredTilson: “I’m watching HOOD”A strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fast...Stansberry Research | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avacta Group Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Avacta Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AVCT Stock Alerts